Foley Senior Counsel R. Brian McCaslin authored an article titled “Are Patent Offices Ready for Personalized Medicine?” in the March/April 2009 issue of Bio-IT World. McCaslin discusses the unique challenges to the patent system presented by new sciences such as personalized medicine, stating that innovators seeking to patent new sciences should consider adapting their prosecution strategy to the current administrative landscape. He adds that innovators should consider postponing the filing date of an application until more information about the new science can be obtained.
Related Insights
June 13, 2025
Foley Viewpoints
Eighth Circuit Affirms Summary Judgment to Insurer in Dispute with Construction Project Owner Over Lost Rental Income
On Monday, June 9, 2025, the Eighth Circuit Court of Appeals ruled that a Missouri real estate developer could not recover insurance…
June 13, 2025
Foley Viewpoints
Your Company Received an ICE Notice of Inspection — Now What?
“Worksite enforcement operations are going to massively expand,” according to a June 12, 2025, interview[1] with Border Czar Tom Homan….
June 13, 2025
Energy Current
Key Provisions of the One Big Beautiful Bill (H.R.1) Related to Foreign Ownership and Foreign Supply (FEOC)
Applicable Limitations on Tax Credits under Sections 48E, 45Y, and 45X: The below summary describes provisions in the One Big Beautiful…